Jialiang Medical Named Hangzhou Quasi-Unicorn and Zhejiang Future Unicorn
GenLight
Innovative Medical Device Solution Provider
'%20fill='%23FFFFFF'%3E%3Crect%20x='249'%20y='126'%20width='1'%20height='1'%3E%3C/rect%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
On the afternoon of April 24, 2025, the 9th "All Things Grow" Conference, hosted by the Zhejiang Provincial Committee of the China Democratic建国 Party, the Zhejiang Provincial Federation of Industry and Commerce, and the China Investment Development Promotion Association, was held in Hangzhou. At the conference, the Hangzhou Venture Capital Association, Welian, and Hangzhou Bank jointly released the series of lists of unicorn companies in Zhejiang Province as well as the 2025 Hangzhou Unicorn and Quasi-Unicorn Enterprise lists.
Genlight Neurotech Successfully Included in the "2025 Soon-to-be-Unicorn Enterprises List" and the "Top 100 Future Unicorn Enterprises in Zhejiang" Lists for Its Outstanding Performance in High-End Medical Technology R&D, Commercialization, and Market Potential.
Since its establishment, Genlight Neurotech has been committed to becoming a trusted leader in solutions for the field of neurology. Being consecutively listed on two prestigious rankings this time not only fully recognizes the company's achievements in technology, products, and market presence, but also serves as the best reward for its development philosophy of upholding independent innovation and benefiting patients!
In the future, Genlight Neurotech will accelerate its pace of innovation, expand its influence in the industry, and contribute to human health!
More rankings:Zhejiang Unicorn、Hangzhou's Near-Unicorn
About Genlight Neurotech
Genlight Neurotech was founded in Hangzhou in 2020 as a high-tech platform enterprise focused on industrializing cutting-edge technologies in the fields of brain science and neurosurgery.
The company has built three advanced technology platforms: brain-computer modulation, medical lasers, and brain-computer chips, providing innovative device solutions for various neurological disorders. Developed products include a magnetic resonance-guided laser ablation surgical system (LITT) for minimally invasive brain surgery, an implantable closed-loop self-responsive neurostimulation system for treating epilepsy and Parkinson’s disease, and deep intracranial electrodes, some of which have entered the formal clinical trial stage.
Genlight Neurotech adheres to the concept of independent innovation and benefiting patients, with a global layout and coordinated development of production and research, striving to become a trusted leader in solutions within the field of neurology.